Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.63%)
At close: Nov 16, 2026 · 4:00 PM EST

Elite Pharmaceuticals (ELTP) Gains from Sales and Divestitures (2020 - 2024)

Updated

Elite Pharmaceuticals (ELTP) reported Gains from Sales and Divestitures of -$121,481 for FY2025 (year ended Mar 31, 2025).

Analysis

Elite Pharmaceuticals (ELTP) Gains from Sales and Divestitures (2020 - 2024) Analysis & Trends

  • The FY2025 figure ranks as the highest annual Gains from Sales and Divestitures since FY2021.
  • According to Business Quant data, Gains from Sales and Divestitures came in at -$292,807 in FY2023 and $48,463 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Elite Pharmaceuticals 401.23 Mn 274.64 Mn 15.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -75,882.00
Jun 30, 2024 -45,599.00
Dec 31, 2020 6,973.00
Sep 30, 2020 3,400.00
Jun 30, 2020 38,090.00
API Access

Elite Pharmaceuticals Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ELTP&period=max&api_key=YOUR_API_KEY